JPRN-UMIN000039903已完成未知
Retrospective study of Initial Acute Decline in eGFR after SGLT2-inhibitor Therapy in Patients with Type-2 Diabetes Mellitus and CKD Stage-3b - Retrospective study of IAD-eGFR by SGLT2i in T2DM and CKD 3b
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 87
研究概览
简要总结
The mean minimum eGFR early after SGLT2i administration was 34.9 mL/min/1.73 m2, which was significantly lower than before treatment (mean, -7.7%). Seventy patients (80.5%) had IAD-eGFR, and 36 patients (41.4%) had a large IAD-eGFR (more than10%).
研究设计
- 研究类型
- Others,meta-analysis etc
入排标准
- 年龄范围
- 20years-old 至 85years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •Type 1 DM unstable condition cancer infection
研究者
相似试验
已完成
不适用
A retrospective study: Effects of additional SGLT2-inhibitor therapy on renal functions in patients with type 2 diabetes mellitus and stage 3b and 4 chronic kidney diseasetype 2 diabetes mellitusJPRN-UMIN000035278Jinnouchi Hospital Diabetes Care Center42
Unknown
2 期
Panitumumab Skin Toxicity Prevention TrialColorectal Cancer MetastaticSkin ToxicityNCT03167268Ospedale San Carlo Borromeo28
尚未招募
3 期
The Effect of Early Initiation of SGLT2 Inhibitors in Reducing Heart Failure Events After MIAcute Coronary SyndromesHeart failureAcute Coronary SyndromesMyocardial in fractionSodiumâ€glucose cotransporter 2 inhibitors (SGLT2i)Heart failureTCTR20200306004Faculty of Medicine, Chiang Mai University476
终止
1 期
A Phase 1/2 study to determine the effect of Doxorubicin loaded EnGeneIC Delivery Vehicles on progression free survival in Patients with Recurrent Glioblastoma Multiforme (GBM)Recurrent Glioblastoma MultiformeCancer - BrainACTRN12613000297729EnGeneIC Ltd46
已完成
Unknown
Single-arm meta-analysis of EGFR-TKI rechallenge or continue treatmentEGFR mutated non-small cell lung cancer patientsJPRN-UMIN000051189Department of Respiratory Minami Kyousai Hospital690